Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005810 · ClinicalTrials.gov registry record · Phase 2
A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 116
- Enrollment target
NCT01005810 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 116 participants.
The verdict
NCT01005810, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 116 participants
- Enrollment target
Study Summary
This study is investigating how N-Acetylcysteine (NAC), an over-the-counter medication, will reduce marijuana use when combined with Contingency Management, a behavioral treatment. It is hypothesized that marijuana dependent adolescents who are treated with NAC will use less marijuana during treatment when compared to adolescents who receive a placebo.
Interventions
- DRUG placebo
- BEHAVIORAL Contingency Management
- DRUG N-Acetylcysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005810
The ClinicalTrials.gov registry entry for NCT01005810 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01005810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01005810 about?
NCT01005810 is a clinical study titled "A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana". This study is investigating how N-Acetylcysteine (NAC), an over-the-counter medication, will reduce marijuana use when combined with Contingency Management, a behavioral treatment. It is hypothesized that marijuana dependent adolescents who are treated with NAC will use less marijuana during treatme...
What is the current status of trial NCT01005810?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2009-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01005810?
The interventions under investigation include: placebo (DRUG), Contingency Management (BEHAVIORAL), N-Acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT01005810?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.